iShares Genomics Immunology and Healthcare ETF
IDNA
84 hedge funds and large institutions have $98.7M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 8 closing their positions.
107% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 15
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
15% more capital invested
Capital invested by funds: $85.8M → $98.7M (+$12.8M)
6% more funds holding
Funds holding: 79 → 84 (+5)
0.6% more ownership
Funds ownership: 26.83% → 27.44% (+0.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCS
Retirement Capital Strategies
San Jose,
California
|
+$3.97M |
| 2 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$2.07M |
| 3 |
CPC
Congress Park Capital
Saratoga Springs,
New York
|
+$1.02M |
| 4 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$962K |
| 5 |
Morgan Stanley
New York
|
+$929K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$8.21M |
| 2 |
OWA
Outlook Wealth Advisors
Shenandoah,
Texas
|
-$747K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$353K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$336K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$247K |
IDNA Hedge Fund Activity: Q2 2021 in Review
84 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q2 2021, worth a combined $98.7M — up 15% from $85.8M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new IDNA positions and 8 closed out — a net gain of 5 holders — while 31 added to existing stakes and 15 trimmed.
The largest buyer was Retirement Capital Strategies, adding an estimated $3.97M. The largest seller was Jane Street, cutting an estimated $8.21M.
- 84 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q2 2021, up from 79 in Q1 2021.
- Funds reported $98.7M of iShares Genomics Immunology and Healthcare ETF stock for Q2 2021, up 15% quarter-over-quarter.
- 13 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q2 2021 and 8 closed out, a net change of +5 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q2 2021 was Retirement Capital Strategies, an estimated $3.97M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q2 2021 was Jane Street, an estimated $8.21M sold.
Based on aggregated 13F filings for Q2 2021.